Andros Pharmaceuticals Co (ROCO:6917) Net Change in Cash : NT$112.34 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Andros Pharmaceuticals Co's Net Change in Cash for the six months ended in Jun. 2024 was NT$-110.86 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was NT$112.34 Mil.

Andros Pharmaceuticals Co Net Change in Cash Historical Data

The historical data trend for Andros Pharmaceuticals Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Net Change in Cash Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

-17.36

-8.96

0.84

73.56

180.82

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial				83.59	-10.03	-42.38	223.20	-110.86

Andros Pharmaceuticals Co Net Change in Cash Calculation

Andros Pharmaceuticals Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-46.64	+	-27.331	+	255.011	+	-0.219
	=	180.82

Andros Pharmaceuticals Co's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -43.32 + -64.366 + -2.54 + -0.634

= -110.86

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$112.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Andros Pharmaceuticals Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Net Change in Cash

Comparable Companies

ROCO:6814 ROCO:3118 ROCO:6549 ROCO:6808 ROCO:4732 ROCO:4131 ROCO:6662 ROCO:6236 ROCO:6652 ROCO:4192 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines